Dan Fan

Changsha, 410011, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Peripheral blood inflammatory markers as predictive and prognostic indicators in neoadjuvant immunotherapy for non-small cell lung cancer.

Peripheral blood inflammatory markers as predictive and prognostic indicators in neoadjuvant immunotherapy for non-small cell lung cancer.

Journal: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences

Published: April 25, 2026

Biomarker-Driven Insights into Immune Checkpoint Inhibitor Therapy in Small-Cell Lung Cancer.

Biomarker-Driven Insights into Immune Checkpoint Inhibitor Therapy in Small-Cell Lung Cancer.

Journal: Critical reviews in oncology/hematology

Published: February 07, 2026

NeoADAURA: Can We Afford to Overlook Objective Response Rates?

NeoADAURA: Can We Afford to Overlook Objective Response Rates?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 19, 2025

Development and validation of a nomogram for predicting the overall survival in non-small cell lung cancer patients with liver metastasis.

Development and validation of a nomogram for predicting the overall survival in non-small cell lung cancer patients with liver metastasis.

Journal: Translational cancer research

Published: May 25, 2023

Case Report: ICIs-induced Guillain-Barré syndrome recovered from mycophenolate mofetil.

Case Report: ICIs-induced Guillain-Barré syndrome recovered from mycophenolate mofetil.

Journal: Frontiers in immunology

Published: December 27, 2022

Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel-based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer.

Tumor regression rate, PD-L1 expression, pembrolizumab/nab-paclitaxel-based regimens, squamous cell carcinoma, and comorbidities were independently associated with efficacy of neoadjuvant chemoimmunotherapy in non-small cell lung cancer.

Journal: Frontiers in oncology

Published: September 29, 2022

TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.

TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence.

Journal: JCO precision oncology

Published: December 14, 2020

Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base.

Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base.

Journal: International journal of particle therapy

Published: March 05, 2020

Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.

Last-line local treatment with the Quad Shot regimen for previously irradiated head and neck cancers.

Journal: Oral oncology

Published: January 31, 2020

Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.

Outcomes and toxicities of definitive radiotherapy and reirradiation using 3-dimensional conformal or intensity-modulated (pencil beam) proton therapy for patients with nasal cavity and paranasal sinus malignancies.

Journal: Cancer

Published: December 18, 2019

Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.

Outcomes of multimodal therapy in a large series of patients with anaplastic thyroid cancer.

Journal: Cancer

Published: January 08, 2019

Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.

Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors.

Journal: Nature communications

Published: April 11, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026